Skip to main content
. 2020 Dec 10;21:87. doi: 10.1186/s40360-020-00464-9

Table 3.

Ratios of serious ADRs to total ADRs for the 20 most common culprit drugs classified by active ingredient

Culprit drugs < 65 years ≥ 65 years Odds ratio (95% CI) P value
Serious / Total ADRs (%)
Analgesics 41/2401 (1.7) 16/929 (1.7) 1.01 (0.56–1.81) 0.977
 Tramadol 24/1606 (1.5) 10/727 (1.4) 0.92 (0.44–1.93) 0.824
 Fentanyl 3/209 (1.4) 3/84 (3.6) 2.54 (0.50–12.86) 0.243
 Nefopam 0/308 (0) 0/70 (0) N/A N/A
 Acetaminophen 14/278 (5.0) 3/48 (6.3) 1.26 (0.35–4.55) 0.727
Contrast media 59/2744 (2.2) 34/775 (4.4) 2.09 (1.36–3.21) 0.001
 Iohexol 4/848 (0.5) 9/247 (3.6) 7.98 (2.44–26.14) < 0.001
 Iopamidol 24/982 (2.4) 7/244 (2.9) 1.18 (0.50–2.77) 0.705
 Iomeprol 7/420 (1.7) 6/93 (6.5) 4.07 (1.34–12.40) 0.008
 Iopromide 16/220 (7.3) 4/83 (4.8) 0.65 (0.21–1.99) 0.443
 Iodixanol 2/103 (1.9) 5/60 (8.3) 4.59 (0.86–24.45) 0.052
 Ioversol 6/171 (3.5) 3/48 (6.3) 1.83 (0.44–7.62) 0.398
Anti-bacterial drugs 60/864 (6.9) 37/424 (8.7) 1.28 (0.84–1.96) 0.255
 Ceftriaxone 16/324 (4.9) 13/104 (12.5) 2.75 (1.28–5.93) 0.008
 Ciprofloxacin 8/174 (4.6) 5/84 (6.0) 1.31 (0.42–4.14) 0.641
 Cefpiramide 1/152 (0.7) 1/72 (1.4) 2.13 (0.13–34.49) 0.587
 Piperacillin 3/52 (5.8) 7/58 (12.1) 2.24 (0.55–9.17) 0.251
 Vancomycin 10/131 (7.6) 7/56 (12.5) 1.73 (0.62–4.08) 0.289
 Cefaclor 22/31 (71.0) 4/50 (8.0) 0.04 (0.01–0.13) < 0.001
Anti-inflammatory and anti-rheumatic drugs 172/2009 (8.6) 39/232 (16.8) 2.16 (1.48–3.15) < 0.001
 Acetic acid 40/507 (7.9) 10/83 (12.0) 1.60 (0.77–3.34) 0.207
 Acetylsalicylic acid 90/749 (12.0) 19/82 (23.2) 2.21 (1.26–3.86) 0.005
 Propionic acid 42/753 (5.6) 10/67 (14.9) 2.97 (1.42–6.23) 0.003
Drugs for acid-related disorders
 Ranitidine 15/251 (6.0) 5/88 (5.7) 0.95 (0.33–2.69) 0.920

Values represent numbers of cases with percentages in parentheses. P values were obtained from the chi-square test

ADR Adverse drug reaction, CI Confidence interval, N/A Not applicable